Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis
BACKGROUND: Global glomerulosclerosis (GS) reflects chronic and irreversible nephron loss; however, its clinical interpretation is limited by age-related increases. We aimed to evaluate the prognostic value of GS using both conventional and age-adjusted approaches in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). MATERIALS AND METHODS: In this retrospective cohort study, patients with biopsy-proven IgAN and FSGS were analyzed. GS was evaluated using both conventional measures and an age-adjusted approach based on reference values derived from healthy kidney donors. The primary outcome was defined as a ≥ 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage kidney disease. Logistic regression and Cox proportional hazards models were used to assess associations with renal outcomes. RESULTS: A total of 218 patients were included in the final analysis, of whom 73 (33.5%) were classified as having age-adjusted excess GS. During a mean follow-up of 45.8 ± 23.8 months, 46 patients (21.1%) reached the renal endpoint. Renal events occurred significantly more frequently in patients with excess GS compared to those with expected GS (46.6 vs. 8.3%, p < 0.001). This corresponded to a significantly higher risk of renal progression in patients with excess GS (OR = 9.66, 95% CI 4.57 - 20.43, p < 0.001). In multivariable Cox analysis, excess GS remained independently associated with renal outcome (HR 5.21, 95% CI 1.97 - 13.73, p = 0.001), whereas conventional GS measures showed weaker associations. Each 10% increase in GS ratio was associated with a 24% higher risk of progression (OR 1.24, p = 0.005). Kaplan-Meier analysis demonstrated significantly worse renal survival in patients with excess GS. CONCLUSION: Age-adjusted GS is a strong and independent predictor of renal outcome in IgAN and FSGS and provides additional prognostic information beyond conventional GS measures.
Authors
- Serkan Aktürk (ORCID: https://orcid.org/0000-0003-2150-2109)
- Murat Duranay (ORCID: https://orcid.org/0000-0002-2893-4484)
- Saba Kiremitçi (ORCID: https://orcid.org/0000-0001-8868-1362)
- Ramazan Öztürk (ORCID: https://orcid.org/0000-0002-4513-1210)
- Alper Zenger
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5414/cn112109
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00